We are live on
!
Find out more
IBBJ
Defiance Nasdaq Junior Biotechnology ETF
IBBJ
IBBJ
Delisted
IBBJ was delisted on the 2nd of December, 2021.
6 hedge funds and large institutions have $1.19M invested in Defiance Nasdaq Junior Biotechnology ETF in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,196% more capital invested
Capital invested by funds: $52K → $1.19M (+$1.14M)
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
200% more funds holding
Funds holding: 2 → 6 (+4)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
6
Holders Change
+4
Holders Change %
+200%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$718K |
| 2 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$257K |
| 3 |
IF
Ironwood Financial
Tucson,
Arizona
|
+$22.1K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$21.5K |
| 5 |
RWB
RMR Wealth Builders
Montclair,
New Jersey
|
+$12.3K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$24K |
| 2 |
EIP
Ellis Investment Partners
Berwyn,
Pennsylvania
|
-$767 |